At a glance
ClinicalIndex Comparison RecordPhase 3Completed
Drug / intervention
Oral dietary supplements (563 kcal/d), RESPIFOR +3 moredrug
Likely dose
160 mg/d of oral testosterone undecanoate in men, 80 mg/d in womenfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Home Pulmonary Rehabilitation in Patients With Chronic Respiratory Failure and Nutritional Depletion.
In Brief
A Phase 3 clinical trial evaluating education, Oral dietary supplements (563 kcal/d), RESPIFOR, and 2 other interventions for Chronic Respiratory Failure and Nutritional Depletion. Completed, across 8 sites in 2 countries.
Detailed Summary
Title : Effects of home pulmonary rehabilitation in patients with chronic respiratory failure and nutritional depletion. This is a randomized controlled, open clinical trial with two groups. * first group, 100 patients : control group, patients followed with no add-on intervention * Second group, 100 patients : rehabilitation group with education, oral supplements, exercise and androgenic steroids.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Respiratory Failure, Nutritional Depletion
CountriesFrance, Switzerland
Timeline
Phase 3CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2003
First PostedOct 2005
Primary CompletionJun 2008
TodayJul 2026
First PostedOct 3, 2005
Enrollment StartApr 1, 2003
Primary CompletionJun 1, 2008
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 20.7 years ago
Interventions
educationbehavioral
Oral dietary supplements (563 kcal/d), RESPIFORdrug
exercises on an ergometric bicycle 3 to 5 times a weekbehavioral
160 mg/d of oral testosterone undecanoate in men, 80 mg/d in womendrug